MENU
ANAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AnaptysBio (ANAB) Earnings Date & Reports
AnaptysBio Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ANAB is expected to report earnings to fall 93.08% to -12 cents per share on September 11
Q2'26
Est.
$-0.13
Q1'26
Missed
by $0.88
Q4'25
Beat
by $0.71
Q3'25
Beat
by $1.92
Q2'25
Beat
by $0.18
The last earnings report on May 12 showed earnings per share of -184 cents, missing the estimate of -95 cents. With 187.70K shares outstanding, the current market capitalization sits at 1.70B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a provider of therapeutic antibodies for inflammation and immuno-oncology
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
104
Web
https://www.anaptysbio.com